- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Experts release cancer guidelines
The National Comprehensive Cancer Network and the American Cancer Society joined together to release the first treatment guidelines for women with breast cancer.
The National Comprehensive Cancer Network and the American Cancer Society joined together to release the first treatment guidelines for women with breast cancer.
Promoted by the organizations as "cancer treatment information for the layperson," the guidelines are pertinent to and intended for physicians as well. Drafted by a panel of National Comprehensive Cancer Network oncology experts from 17 leading cancer centers, the guidelines make specific treatment recommendations about all types and stages of breast cancer for women. (Treatment for male breast cancer, a rare form of cancer that requires different therapies, is not addressed within the guidelines.)
Those who view the guidelines via the American Cancer Society's Web site, www.cancer.org, can wind their way through algorithms or what physicians call "decision trees." Each decision tree is organized according to what stage of cancer is being treated, and it shows patients the step-by-step process by which the patient and doctor arrive at treatment decisions.
Zeneca's Nolvadex (tamoxifen) is referenced throughout the guidelines as adjuvant therapy to chemotherapy. It is the only product specifically mentioned in the guidelines.
For more information on the guidelines, call the National Comprehensive Cancer Network at (888) 909-6226 or the American Cancer Society at (800) 227-2345. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
